Kennedy Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4M | Sell |
267,030
-19,746
| -7% | -$1.29M | 0.42% | 58 |
|
|
2025
Q1 | $19.2M | Buy |
286,776
+100,501
| +54% | +$6.73M | 0.46% | 44 |
|
|
2024
Q4 | $10.3M | Sell |
186,275
-2,532
| -1% | -$140K | 0.23% | 133 |
|
|
2024
Q3 | $11.3M | Sell |
188,807
-9,247
| -5% | -$552K | 0.25% | 118 |
|
|
2024
Q2 | $12.6M | Sell |
198,054
-11,972
| -6% | -$762K | 0.27% | 112 |
|
|
2024
Q1 | $14.5M | Sell |
210,026
-18,928
| -8% | -$1.31M | 0.3% | 92 |
|
|
2023
Q4 | $12.6M | Buy |
228,954
+10,882
| +5% | +$600K | 0.28% | 108 |
|
|
2023
Q3 | $12.7M | Sell |
218,072
-91,815
| -30% | -$5.33M | 0.31% | 89 |
|
|
2023
Q2 | $16.7M | Buy |
309,887
+27,266
| +10% | +$1.47M | 0.39% | 55 |
|
|
2023
Q1 | $11.2M | Sell |
282,621
-77,873
| -22% | -$3.09M | 0.33% | 79 |
|
|
2022
Q4 | $14.5M | Buy |
360,494
+18,044
| +5% | +$726K | 0.41% | 63 |
|
|
2022
Q3 | $11M | Buy |
342,450
+180,376
| +111% | +$5.8M | 0.32% | 92 |
|
|
2022
Q2 | $4.81M | Buy |
+162,074
| New | +$4.81M | 0.13% | 274 |
|
|
2017
Q3 | – | Sell |
-57,115
| Closed | -$2.67M | – | 735 |
|
|
2017
Q2 | $2.67M | Sell |
57,115
-25,062
| -30% | -$1.17M | 0.05% | 543 |
|
|
2017
Q1 | $4.07M | Buy |
+82,177
| New | +$4.07M | 0.07% | 469 |
|
|
2016
Q2 | – | Sell |
-15,000
| Closed | -$505K | – | 708 |
|
|
2016
Q1 | $505K | Buy |
+15,000
| New | +$505K | 0.01% | 696 |
|
|
2014
Q2 | – | Sell |
-201,231
| Closed | -$6.31M | – | 744 |
|
|
2014
Q1 | $6.31M | Buy |
201,231
+63,287
| +46% | +$1.98M | 0.12% | 324 |
|
|
2013
Q4 | $2.77M | Buy |
137,944
+27,497
| +25% | +$552K | 0.05% | 493 |
|
|
2013
Q3 | $1.08M | Buy |
+110,447
| New | +$1.08M | 0.02% | 632 |
|